Cell Based Assays Market by Offering (Reagents, Assays Kits, Cell Lines, Microplates, Probes, Labels, Instruments & Software), Technology (Flowcytometry, HTS), Application (Drug Discovery (Toxicity, Pharmacokinetics), Research) - Global Forecast to 2029

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
• 2.2 MARKET ESTIMATION METHODOLOGY
  • 2.2.1 BOTTOM-UP APPROACH
  • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
  • 2.2.3 TOP-DOWN APPROACH
• 2.3 MARKET GROWTH RATE PROJECTIONS
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RISK ANALYSIS
• 2.7 LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 CELL-BASED ASSAYS MARKET OVERVIEW
• 4.2 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER AND COUNTRY (2023)
• 4.3 CELL-BASED ASSAYS MARKET, BY OFFERING, 2023
• 4.4 CELL-BASED ASSAYS MARKET, BY END USER, 2023
• 4.5 CELL-BASED ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing demand for drug discovery & development and increasing preference for cell-based assays in drug discovery
    • 5.2.1.2 Government support and funding for cell-based research
    • 5.2.1.3 Growing efforts to curtail animal-based studies
    • 5.2.1.4 Rising prevalence of cancer
    • 5.2.1.5 Alliances to accelerate innovations in drug discovery
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of instruments and restrictions imposed by product end-user licenses for reagents
    • 5.2.2.2 Lack of standardization of protocols used in cell-based assays
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing applications of cell-based assays in chronic diseases and personalized medicine
    • 5.2.3.2 Growth opportunities in emerging economies
    • 5.2.3.3 Rising adoption of AI in drug discovery and cell analysis
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Complexities in assay designs
    • 5.2.4.2 Shortage of skilled professionals
• 5.3 TECHNOLOGY ANALYSIS
  • 5.3.1 KEY TECHNOLOGIES
    • 5.3.1.1 Flow Cytometry
    • 5.3.1.2 High-throughput screening
    • 5.3.1.3 High-content screening
    • 5.3.1.4 Label-free detection
  • 5.3.2 COMPLEMENTARY TECHNOLOGIES
    • 5.3.2.1 Artificial intelligence and machine learning
  • 5.3.3 ADJACENT TECHNOLOGIES
    • 5.3.3.1 Nanotechnology
• 5.4 SUPPLY CHAIN ANALYSIS
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 PRICING ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
  • 5.7.1 RAW MATERIAL VENDORS
  • 5.7.2 PRODUCT/SERVICE VENDORS
  • 5.7.3 END USERS
  • 5.7.4 REGULATORY BODIES
• 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.9 PATENT ANALYSIS
  • 5.9.1 PATENT METHODOLOGY
  • 5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
  • 5.9.3 INNOVATION & PATENT APPLICATIONS
  • 5.9.4 TOP APPLICANTS
• 5.10 KEY CONFERENCES & EVENTS, 2024-2025
• 5.11 REGULATORY LANDSCAPE
  • 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11.2 REGULATORY SCENARIO
• 5.12 PORTER'S FIVE FORCES ANALYSIS
  • 5.12.1 THREAT OF NEW ENTRANTS
  • 5.12.2 THREAT OF SUBSTITUTES
  • 5.12.3 BARGAINING POWER OF SUPPLIERS
  • 5.12.4 BARGAINING POWER OF BUYERS
  • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 BUYING CRITERIA
• 5.14 INVESTMENT & FUNDING SCENARIO
• 5.15 TRADE ANALYSIS
• 5.16 IMPACT OF AI/GENERATIVE AI ON CELL-BASED ASSAYS MARKET

6 CELL-BASED ASSAYS MARKET, BY OFFERING

• 6.1 INTRODUCTION
• 6.2 CONSUMABLES
  • 6.2.1 REAGENTS
    • 6.2.1.1 High demand for reagents in research applications to propel market growth
  • 6.2.2 ASSAY KITS
    • 6.2.2.1 Reporter gene assays
      • 6.2.2.1.1 Versatility of reporter gene assays and widespread applications to fuel growth
    • 6.2.2.2 Cell growth assays
      • 6.2.2.2.1 Rising use of cell viability and cell proliferation assays for assessing cell growth to boost market
    • 6.2.2.3 Second messenger assays
      • 6.2.2.3.1 Adoption of secondary messenger assays for cell signaling studies to fuel growth
    • 6.2.2.4 Cell death assays
      • 6.2.2.4.1 Importance of cell death quantification in drug development to favor growth
    • 6.2.2.5 Other assay kits
  • 6.2.3 MICROPLATES
    • 6.2.3.1 Demand for microplates in assay development to drive market
  • 6.2.4 CELL LINES
    • 6.2.4.1 Immortalized cell lines
      • 6.2.4.1.1 Wide use of immortalized cell lines to boost market
    • 6.2.4.2 Primary cell lines
      • 6.2.4.2.1 Advantages in drug development, preclinical research, and other applications to propel market
    • 6.2.4.3 Stem cell lines
      • 6.2.4.3.1 Rising use in tissue and disease models to fuel adoption
  • 6.2.5 PROBES & LABELS
    • 6.2.5.1 Growing need for effective cell labeling to boost demand
  • 6.2.6 OTHER CONSUMABLES
• 6.3 INSTRUMENTS
  • 6.3.1 AUTOMATION IN INSTRUMENTS TO DRIVE SEGMENTAL GROWTH
• 6.4 SERVICES
  • 6.4.1 GROWING NUMBER OF CROS PROVIDING DRUG DISCOVERY AND SCREENING SERVICES TO ACCELERATE GROWTH
• 6.5 SOFTWARE
  • 6.5.1 INCREASING ADOPTION OF SOFTWARE FOR EFFICIENT DATA ANALYSIS TO DRIVE GROWTH

7 CELL-BASED ASSAYS MARKET, BY TECHNOLOGY

• 7.1 INTRODUCTION
• 7.2 FLOW CYTOMETRY
  • 7.2.1 WIDE USAGE OF FLOW CYTOMETRY IN CELL-BASED ASSAYS TO DRIVE MARKET
• 7.3 HIGH-THROUGHPUT SCREENING
  • 7.3.1 INCREASING INVESTMENTS AND FUNDING FOR LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH
• 7.4 LABEL-FREE DETECTION
  • 7.4.1 GROWING ADOPTION OF ADVANCED TECHNOLOGIES TO DRIVE DEMAND
• 7.5 OTHER TECHNOLOGIES

8 CELL-BASED ASSAYS MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 DRUG DISCOVERY
  • 8.2.1 TOXICITY STUDIES
    • 8.2.1.1 Increasing demand for cell-based assays in toxicity testing to fuel growth
  • 8.2.2 PHARMACOKINETIC STUDIES
    • 8.2.2.1 Growing focus on ADME studies in pharmacokinetics to propel demand for cell-based assays
  • 8.2.3 PHARMACODYNAMIC STUDIES
    • 8.2.3.1 Advantages of cell-based assays in pharmacodynamics to propel growth
• 8.3 BASIC RESEARCH
  • 8.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES
• 8.4 GENETIC STUDIES
  • 8.4.1 INCREASING FUNDING FOR GENETIC RESEARCH TO DRIVE MARKET
• 8.5 OTHER APPLICATIONS

9 CELL-BASED ASSAYS MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO HOLD LARGEST SHARE OF END-USER MARKET
• 9.3 CONTRACT RESEARCH ORGANIZATIONS
  • 9.3.1 GROWING PREFERENCE FOR OUTSOURCING TO DRIVE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH
• 9.4 ACADEMIC & RESEARCH INSTITUTES
  • 9.4.1 RISING FOCUS ON DEVELOPING ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE MARKET

10 CELL-BASED ASSAYS MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
  • 10.2.2 US
    • 10.2.2.1 US to dominate North American cell-based assays market during forecast period
  • 10.2.3 CANADA
    • 10.2.3.1 Increasing funding and investments to drive market in Canada
• 10.3 EUROPE
  • 10.3.1 EUROPE: MACROECONOMIC OUTLOOK
  • 10.3.2 GERMANY
    • 10.3.2.1 Germany to dominate cell-based assays market in Europe
  • 10.3.3 UK
    • 10.3.3.1 Growing cancer research funding to increase demand for cell-based assays
  • 10.3.4 FRANCE
    • 10.3.4.1 Growing biotechnology sector to drive market
  • 10.3.5 ITALY
    • 10.3.5.1 Growing pharmaceutical industry in Italy to boost market
  • 10.3.6 SPAIN
    • 10.3.6.1 Rising research activity and increasing number of biotech companies to favor market growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
  • 10.4.2 CHINA
    • 10.4.2.1 Increasing R&D expenditure to favor market growth
  • 10.4.3 JAPAN
    • 10.4.3.1 Government initiatives for drug innovation to support market growth
  • 10.4.4 INDIA
    • 10.4.4.1 Increasing investments in R&D and funding for life science research to propel market
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Booming life science sector to propel market
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Increasing strategic alliances to support market growth
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
  • 10.5.2 BRAZIL
    • 10.5.2.1 Brazil to hold largest share of Latin American market
  • 10.5.3 MEXICO
    • 10.5.3.1 Government support for biopharmaceutical production to support market growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST
  • 10.6.1 MIDDLE EAST: MACROECONOMIC OUTLOOK
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Saudi Arabia
      • 10.6.2.1.1 Increasing R&D investments to drive market
    • 10.6.2.2 UAE
      • 10.6.2.2.1 Investments and support for biopharma sector to offer growth opportunities
    • 10.6.2.3 Rest of GCC Countries
  • 10.6.3 REST OF MIDDLE EAST
• 10.7 AFRICA
  • 10.7.1 RISING NEED FOR EFFECTIVE DIAGNOSTICS TO SUPPORT MARKET GROWTH
  • 10.7.2 AFRICA: MACROECONOMIC OUTLOOK

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL-BASED ASSAYS MARKET
• 11.3 REVENUE ANALYSIS
• 11.4 MARKET SHARE ANALYSIS
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Offering footprint
    • 11.5.5.3 Technology footprint
    • 11.5.5.4 Application Footprint
    • 11.5.5.5 Region footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 11.7 VALUATION AND FINANCIAL METRICS
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

• 12.1 INTRODUCTION
• 12.2 KEY PLAYERS
  • 12.2.1 DANAHER CORPORATION
    • 12.2.1.1 Business overview
    • 12.2.1.2 Products/Services offered
    • 12.2.1.3 Recent developments
      • 12.2.1.3.1 Deals
      • 12.2.1.3.2 Expansions
    • 12.2.1.4 MnM view
      • 12.2.1.4.1 Key strengths
      • 12.2.1.4.2 Strategic choices
      • 12.2.1.4.3 Weaknesses & competitive threats
  • 12.2.2 THERMO FISHER SCIENTIFIC INC.
    • 12.2.2.1 Business overview
    • 12.2.2.2 Products/Services offered
    • 12.2.2.3 Recent developments
      • 12.2.2.3.1 Deals
      • 12.2.2.3.2 Expansions
    • 12.2.2.4 MnM view
      • 12.2.2.4.1 Key strengths
      • 12.2.2.4.2 Strategic choices
      • 12.2.2.4.3 Weaknesses and competitive threats
  • 12.2.3 MERCK KGAA
    • 12.2.3.1 Business overview
    • 12.2.3.2 Products/Services offered
    • 12.2.3.3 Recent developments
      • 12.2.3.3.1 Deals
      • 12.2.3.3.2 Expansions
    • 12.2.3.4 MnM view
      • 12.2.3.4.1 Key strengths
      • 12.2.3.4.2 Strategic choices
      • 12.2.3.4.3 Weaknesses and competitive threats
  • 12.2.4 BD
    • 12.2.4.1 Business overview
    • 12.2.4.2 Products/Services offered
    • 12.2.4.3 Recent developments
      • 12.2.4.3.1 Product launches
      • 12.2.4.3.2 Deals
    • 12.2.4.4 MnM view
      • 12.2.4.4.1 Key strengths
      • 12.2.4.4.2 Strategic choices
      • 12.2.4.4.3 Weaknesses and competitive threats
  • 12.2.5 AGILENT TECHNOLOGIES, INC.
    • 12.2.5.1 Business overview
    • 12.2.5.2 Products/Services offered
    • 12.2.5.3 Recent developments
      • 12.2.5.3.1 Product launches
    • 12.2.5.4 MnM view
      • 12.2.5.4.1 Key strengths
      • 12.2.5.4.2 Strategic choices
      • 12.2.5.4.3 Weaknesses & competitive threats
  • 12.2.6 LONZA
    • 12.2.6.1 Business overview
    • 12.2.6.2 Products/Services offered
    • 12.2.6.3 Recent developments
      • 12.2.6.3.1 Deals
      • 12.2.6.3.2 Expansions
  • 12.2.7 EUROFINS SCIENTIFIC
    • 12.2.7.1 Business overview
    • 12.2.7.2 Products/Services offered
    • 12.2.7.3 Recent developments
      • 12.2.7.3.1 Deals
  • 12.2.8 CHARLES RIVER LABORATORIES
    • 12.2.8.1 Business overview
    • 12.2.8.2 Products/services offered
    • 12.2.8.3 Recent developments
      • 12.2.8.3.1 Service launches
      • 12.2.8.3.2 Deals
  • 12.2.9 BIO-RAD LABORATORIES, INC.
    • 12.2.9.1 Business overview
    • 12.2.9.2 Products/Services offered
  • 12.2.10 REVVITY
    • 12.2.10.1 Business overview
    • 12.2.10.2 Products/Services offered
    • 12.2.10.3 Recent developments
      • 12.2.10.3.1 Product launches
  • 12.2.11 SARTORIUS AG
    • 12.2.11.1 Business overview
    • 12.2.11.2 Products/Services offered
    • 12.2.11.3 Recent developments
      • 12.2.11.3.1 Expansions
  • 12.2.12 CORNING INCORPORATED
    • 12.2.12.1 Business overview
    • 12.2.12.2 Products/Services offered
  • 12.2.13 PROMEGA CORPORATION
    • 12.2.13.1 Business overview
    • 12.2.13.2 Products/Services offered
  • 12.2.14 CELL SIGNALING TECHNOLOGY, INC.
    • 12.2.14.1 Business overview
    • 12.2.14.2 Products/Services offered
  • 12.2.15 ENZO BIOCHEM INC.
    • 12.2.15.1 Business overview
    • 12.2.15.2 Products/Services offered
    • 12.2.15.3 Recent developments
      • 12.2.15.3.1 Expansions
  • 12.2.16 CARNA BIOSCIENCES, INC.
    • 12.2.16.1 Business overview
    • 12.2.16.2 Products/Services offered
  • 12.2.17 INTERTEK GROUP PLC
    • 12.2.17.1 Business overview
    • 12.2.17.2 Products/services offered
  • 12.2.18 BICO
    • 12.2.18.1 Business overview
    • 12.2.18.2 Products/Services offered
• 12.3 OTHER PLAYERS
  • 12.3.1 CELL BIOLABS, INC.
  • 12.3.2 REACTION BIOLOGY
  • 12.3.3 AAT BIOQUEST, INC.
  • 12.3.4 PESTKA BIOMEDICAL LABORATORIES, INC.
  • 12.3.5 NEUROMICS
  • 12.3.6 BPS BIOSCIENCE, INC.
  • 12.3.7 BELLBROOK LABS
  • 12.3.8 PROFACGEN
  • 12.3.9 BMG LABTECH
  • 12.3.10 HANUGEN THERAPEUTICS
  • 12.3.11 ALTOGEN LABS
  • 12.3.12 BIOAGILYTIX

13 DISCUSSION GUIDE

• 13.1 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.2 CUSTOMIZATION OPTIONS
• 13.3 RELATED REPORTS
• 13.4 AUTHOR DETAILS

List of Tables

• TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
• TABLE 2 CELL-BASED ASSAYS MARKET: IMPACT ANALYSIS
• TABLE 3 ESTIMATED EXPENDITURE BY US NIH FOR STEM CELL RESEARCH, 2019-2025
• TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2022 VS. 2035
• TABLE 5 CELL-BASED ASSAYS MARKET: KEY DEVELOPMENTS REPORTED, BY PLAYER
• TABLE 6 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021-2023
• TABLE 7 AVERAGE SELLING PRICE FOR CELL-BASED ASSAYS, BY REGION, 2023
• TABLE 8 CELL-BASED ASSAYS MARKET: ROLE OF RAW MATERIAL VENDORS
• TABLE 9 CELL-BASED ASSAYS MARKET: ROLE OF PRODUCT/SERVICE VENDORS
• TABLE 10 CELL-BASED ASSAYS MARKET: ROLE OF END USERS
• TABLE 11 CELL-BASED ASSAYS MARKET: ROLE OF REGULATORY BODIES
• TABLE 12 PATENTS FILED, 2014-2024
• TABLE 13 TOP 20 PATENT OWNERS IN CELL-BASED ASSAYS MARKET, 2014-2024
• TABLE 14 INDICATIVE LIST OF PATENTS IN CELL-BASED ASSAYS MARKET
• TABLE 15 CELL-BASED ASSAYS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS
• TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 20 CELL-BASED ASSAYS MARKET: REGULATORY GUIDELINES
• TABLE 21 CELL-BASED ASSAYS MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 22 BUYING CRITERIA FOR CELL-BASED ASSAY PRODUCTS, BY END USER
• TABLE 23 IMPORT VALUE FOR HS CODE 9027 (TOP 20 COUNTRIES), 2019-2023 (USD THOUSAND)
• TABLE 24 EXPORT VALUE FOR HS CODE 9027 (TOP 20 COUNTRIES), 2019-2023 (USD THOUSAND)
• TABLE 25 IMPORT VOLUME FOR HS CODE 9027 (TOP 20 COUNTRIES), 2019-2023 (TONS)
• TABLE 26 EXPORT VOLUME FOR HS CODE 9027 (TOP 20 COUNTRIES), 2019-2023 (TONS)
• TABLE 27 CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 28 CONSUMABLES OFFERED, BY KEY COMPANY
• TABLE 29 CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 30 CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 31 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 32 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 33 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 34 LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 35 MIDDLE EAST: CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 36 GCC COUNTRIES: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 37 REAGENTS OFFERED, BY KEY COMPANY
• TABLE 38 REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 39 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 40 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 41 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 42 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 43 MIDDLE EAST: REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 44 GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 45 ASSAY KITS OFFERED, BY KEY COMPANY
• TABLE 46 ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 47 ASSAY KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 48 NORTH AMERICA: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 49 EUROPE: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 50 ASIA PACIFIC: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 51 LATIN AMERICA: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 52 MIDDLE EAST: ASSAY KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 53 GCC COUNTRIES: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 54 REPORTER GENE ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 55 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 56 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 57 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 58 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 59 MIDDLE EAST: REPORTER GENE ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 60 GCC COUNTRIES: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 61 CELL GROWTH ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 62 NORTH AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 63 EUROPE: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 64 ASIA PACIFIC: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 65 LATIN AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 66 MIDDLE EAST: CELL GROWTH ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 67 GCC COUNTRIES: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 68 SECONDARY MESSENGER ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 69 NORTH AMERICA: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 70 EUROPE: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 71 ASIA PACIFIC: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 72 LATIN AMERICA: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 73 MIDDLE EAST: SECONDARY MESSENGER ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 74 GCC COUNTRIES: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 75 CELL DEATH ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 76 NORTH AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 77 EUROPE: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 78 ASIA PACIFIC: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 79 LATIN AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 80 MIDDLE EAST: CELL DEATH ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 81 GCC COUNTRIES: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 82 OTHER ASSAY KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 83 NORTH AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 84 EUROPE: OTHER ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 85 ASIA PACIFIC: OTHER ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 86 LATIN AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 87 MIDDLE EAST: OTHER ASSAY KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 88 GCC COUNTRIES: OTHER ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 89 MICROPLATES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 90 NORTH AMERICA: MICROPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 91 EUROPE: MICROPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 92 ASIA PACIFIC: MICROPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 93 LATIN AMERICA: MICROPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 94 MIDDLE EAST: MICROPLATES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 95 GCC COUNTRIES: MICROPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 96 CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 97 CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 98 NORTH AMERICA: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 99 EUROPE: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 100 ASIA PACIFIC: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 101 LATIN AMERICA: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 102 MIDDLE EAST: CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 103 GCC COUNTRIES: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 104 IMMORTALIZED CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 105 NORTH AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 106 EUROPE: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 107 ASIA PACIFIC: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 108 LATIN AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 109 MIDDLE EAST: IMMORTALIZED CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 110 GCC COUNTRIES: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 111 PRIMARY CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 112 NORTH AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 113 EUROPE: PRIMARY CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 114 ASIA PACIFIC: PRIMARY CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 115 LATIN AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 116 MIDDLE EAST: PRIMARY CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 117 GCC COUNTRIES: PRIMARY CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 118 STEM CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 119 NORTH AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 120 EUROPE: STEM CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 121 ASIA PACIFIC: STEM CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 122 LATIN AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 123 MIDDLE EAST: STEM CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 124 GCC COUNTRIES: STEM CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 125 PROBES & LABELS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 126 NORTH AMERICA: PROBES & LABELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 127 EUROPE: PROBES & LABELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 128 ASIA PACIFIC: PROBES & LABELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 129 LATIN AMERICA: PROBES & LABELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 130 MIDDLE EAST: PROBES & LABELS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 131 GCC COUNTRIES: PROBES & LABELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 132 OTHER CONSUMABLES OFFERED, BY KEY COMPANY
• TABLE 133 OTHER CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 134 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 135 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 136 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 137 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 138 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 139 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 140 INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 141 NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 142 EUROPE: INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 143 ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 144 LATIN AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 145 MIDDLE EAST: INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 146 GCC COUNTRIES: INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 147 SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 148 NORTH AMERICA: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 149 EUROPE: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 150 ASIA PACIFIC: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 151 LATIN AMERICA: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 152 MIDDLE EAST: SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 153 GCC COUNTRIES: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 154 SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 155 NORTH AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 156 EUROPE: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 157 ASIA PACIFIC: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 158 LATIN AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 159 MIDDLE EAST: SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 160 GCC COUNTRIES: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 161 CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 162 CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2029 (USD MILLION)
• TABLE 163 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 164 EUROPE: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 165 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 166 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 167 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2029 (USD MILLION)
• TABLE 168 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 169 CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2022-2029 (USD MILLION)
• TABLE 170 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 171 EUROPE: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 172 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 173 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 174 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2022-2029 (USD MILLION)
• TABLE 175 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 176 CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 177 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 178 EUROPE: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 179 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 180 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 181 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 182 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 183 OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 184 NORTH AMERICA: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 185 EUROPE: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 186 ASIA PACIFIC: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 187 LATIN AMERICA: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 188 MIDDLE EAST: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 189 GCC COUNTRIES: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 190 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 191 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 192 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 193 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 194 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 195 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 196 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 197 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 198 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 199 CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 200 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 201 EUROPE: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 202 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 203 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 204 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 205 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 206 CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 207 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 208 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 209 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 210 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 211 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 212 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 213 CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 214 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 215 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 216 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 217 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 218 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 219 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 220 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION, 2022-2029 (USD MILLION)
• TABLE 221 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 222 EUROPE: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 223 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 224 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 225 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION, 2022-2029 (USD MILLION)
• TABLE 226 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 227 CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 228 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 229 EUROPE: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 230 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 231 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 232 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 233 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 234 CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 235 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 236 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 237 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 238 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 239 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 240 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 241 CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 242 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION)
• TABLE 243 CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 244 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 245 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 246 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 247 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 248 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 249 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 250 CELL-BASED ASSAYS MARKET FOR CROS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 251 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 252 EUROPE: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 253 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 254 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 255 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR CROS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 256 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 257 CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 258 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 259 EUROPE: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 260 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 261 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 262 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 263 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 264 CELL-BASED ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 265 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 266 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 267 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 268 NORTH AMERICA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 269 NORTH AMERICA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 270 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 271 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 272 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 273 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 274 US: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 275 US: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 276 US: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 277 US: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 278 US: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 279 US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 280 US: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 281 US: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 282 CANADA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 283 CANADA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 284 CANADA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 285 CANADA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 286 CANADA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 287 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 288 CANADA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 289 CANADA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 290 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 291 EUROPE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 292 EUROPE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 293 EUROPE: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 294 EUROPE: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 295 EUROPE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 296 EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 297 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 298 EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 299 GERMANY: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 300 GERMANY: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 301 GERMANY: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 302 GERMANY: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 303 GERMANY: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 304 GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 305 GERMANY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 306 GERMANY: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 307 UK: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 308 UK: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 309 UK: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 310 UK: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 311 UK: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 312 UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 313 UK: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 314 UK: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 315 FRANCE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 316 FRANCE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 317 FRANCE: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 318 FRANCE: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 319 FRANCE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 320 FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 321 FRANCE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 322 FRANCE: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 323 ITALY: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 324 ITALY: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 325 ITALY: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 326 ITALY: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 327 ITALY: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 328 ITALY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 329 ITALY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 330 ITALY: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 331 SPAIN: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 332 SPAIN: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 333 SPAIN: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 334 SPAIN: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 335 SPAIN: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 336 SPAIN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 337 SPAIN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 338 SPAIN: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 339 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 340 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 341 REST OF EUROPE: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 342 REST OF EUROPE: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 343 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 344 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 345 REST OF EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 346 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 347 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 348 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 349 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 350 ASIA PACIFIC: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 351 ASIA PACIFIC: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 352 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 353 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 354 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 355 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 356 CHINA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 357 CHINA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 358 CHINA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 359 CHINA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 360 CHINA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 361 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 362 CHINA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 363 CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 364 JAPAN: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 365 JAPAN: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 366 JAPAN: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 367 JAPAN: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 368 JAPAN: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 369 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 370 JAPAN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 371 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 372 INDIA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 373 INDIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 374 INDIA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 375 INDIA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 376 INDIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 377 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 378 INDIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 379 INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 380 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 381 AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 382 AUSTRALIA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 383 AUSTRALIA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 384 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 385 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 386 AUSTRALIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 387 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 388 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 389 SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 390 SOUTH KOREA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 391 SOUTH KOREA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 392 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 393 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 394 SOUTH KOREA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 395 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 396 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 397 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 398 REST OF ASIA PACIFIC: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 399 REST OF ASIA PACIFIC: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 400 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 401 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 402 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 403 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 404 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 405 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 406 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 407 LATIN AMERICA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 408 LATIN AMERICA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 409 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 410 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 411 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 412 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 413 BRAZIL: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 414 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 415 BRAZIL: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 416 BRAZIL: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 417 BRAZIL: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 418 BRAZIL: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 419 BRAZIL: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 420 BRAZIL: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 421 MEXICO: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 422 MEXICO: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 423 MEXICO: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 424 MEXICO: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 425 MEXICO: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 426 MEXICO: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 427 MEXICO: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 428 MEXICO: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 429 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 430 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 431 REST OF LATIN AMERICA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 432 REST OF LATIN AMERICA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 433 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 434 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 435 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 436 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 437 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 438 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 439 MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 440 MIDDLE EAST: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 441 MIDDLE EAST: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 442 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 443 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 444 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 445 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 446 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 447 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 448 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 449 GCC COUNTRIES: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 450 GCC COUNTRIES: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 451 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 452 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 453 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 454 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 455 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 456 SAUDI ARABIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 457 SAUDI ARABIA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 458 SAUDI ARABIA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 459 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 460 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 461 SAUDI ARABIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 462 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 463 UAE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 464 UAE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 465 UAE: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 466 UAE: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 467 UAE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 468 UAE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 469 UAE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 470 UAE: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 471 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 472 REST OF GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 473 REST OF GCC COUNTRIES: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 474 REST OF GCC COUNTRIES: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 475 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 476 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 477 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 478 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 479 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 480 REST OF MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 481 REST OF MIDDLE EAST: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 482 REST OF MIDDLE EAST: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 483 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 484 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 485 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 486 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 487 AFRICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
• TABLE 488 AFRICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 489 AFRICA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 490 AFRICA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 491 AFRICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 492 AFRICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 493 AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 494 AFRICA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 495 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
• TABLE 496 CELL-BASED ASSAYS MARKET: DEGREE OF COMPETITION
• TABLE 497 CELL-BASED ASSAYS MARKET: OFFERING FOOTPRINT
• TABLE 498 CELL-BASED ASSAYS MARKET: TECHNOLOGY FOOTPRINT
• TABLE 499 CELL-BASED ASSAYS MARKET: APPLICATION FOOTPRINT
• TABLE 500 CELL-BASED ASSAYS MARKET: REGION FOOTPRINT
• TABLE 501 CELL-BASED ASSAYS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
• TABLE 502 CELL-BASED ASSAYS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
• TABLE 503 CELL-BASED ASSAYS MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
• TABLE 504 CELL-BASED ASSAYS MARKET: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 505 CELL-BASED ASSAYS MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 506 DANAHER CORPORATION: COMPANY OVERVIEW
• TABLE 507 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 508 DANAHER CORPORATION DEALS, JANUARY 2021-AUGUST 2024
• TABLE 509 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 510 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
• TABLE 511 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
• TABLE 512 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 513 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 514 MERCK KGAA: COMPANY OVERVIEW
• TABLE 515 MERCK KGAA: PRODUCTS/SERVICES OFFERED
• TABLE 516 MERCK KGAA: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 517 MERCK KGAA (GERMANY): EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 518 BD: BUSINESS OVERVIEW
• TABLE 519 BD: PRODUCTS/SERVICES OFFERED
• TABLE 520 BD: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 521 BD: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 522 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
• TABLE 523 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
• TABLE 524 AGILENT TECHNOLOGIES, INC.: PRODUCTS LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 525 LONZA: COMPANY OVERVIEW
• TABLE 526 LONZA: PRODUCTS/SERVICES OFFERED
• TABLE 527 LONZA: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 528 LONZA: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 529 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
• TABLE 530 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
• TABLE 531 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 532 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
• TABLE 533 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED
• TABLE 534 CHARLES RIVER LABORATORIES: SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 535 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 536 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
• TABLE 537 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
• TABLE 538 REVVITY: COMPANY OVERVIEW
• TABLE 539 REVVITY: PRODUCTS/SERVICES OFFERED
• TABLE 540 REVVITY: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 541 SARTORIUS AG: COMPANY OVERVIEW
• TABLE 542 SARTORIUS AG: PRODUCTS/SERVICES OFFERED
• TABLE 543 SARTORIUS AG: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 544 CORNING INCORPORATED: COMPANY OVERVIEW
• TABLE 545 CORNING INCORPORATED: PRODUCTS/SERVICES OFFERED
• TABLE 546 PROMEGA CORPORATION: COMPANY OVERVIEW
• TABLE 547 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 548 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW
• TABLE 549 CELL SIGNALING TECHNOLOGY, INC.: PRODUCTS/SERVICES OFFERED
• TABLE 550 ENZO BIOCHEM INC.: COMPANY OVERVIEW
• TABLE 551 ENZO BIOCHEM INC.: PRODUCTS/SERVICES OFFERED
• TABLE 552 ENZO BIOCHEM INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 553 CARNA BIOSCIENCES, INC.: BUSINESS OVERVIEW
• TABLE 554 CARNA BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED
• TABLE 555 INTERTEK GROUP PLC: COMPANY OVERVIEW
• TABLE 556 INTERTEK GROUP: PRODUCTS /SERVICES OFFERED
• TABLE 557 BICO: COMPANY OVERVIEW
• TABLE 558 BICO: PRODUCTS/SERVICES OFFERED

List of Figures

• FIGURE 1 RESEARCH DESIGN
• FIGURE 2 BREAKDOWN OF PRIMARIES: CELL-BASED ASSAYS MARKET
• FIGURE 3 CELL-BASED ASSAYS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
• FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
• FIGURE 5 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS (2023)
• FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
• FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
• FIGURE 8 CELL-BASED ASSAYS MARKET: CAGR PROJECTIONS
• FIGURE 9 DATA TRIANGULATION METHODOLOGY
• FIGURE 10 CELL-BASED ASSAYS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
• FIGURE 11 CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
• FIGURE 12 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 13 CELL-BASED ASSAYS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 14 GEOGRAPHICAL SNAPSHOT OF CELL-BASED ASSAYS MARKET
• FIGURE 15 GROWING DEMAND FOR DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET
• FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2023
• FIGURE 17 CONSUMABLES SEGMENT ACCOUNTED FOR LARGER MARKET SHARE IN 2023
• FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT HELD MAJOR MARKET SHARE IN 2023
• FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
• FIGURE 20 CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 21 AGE-STANDARDIZED RATE (WORLD) PER 100,000 CANCER INCIDENCES IN BOTH SEXES, 2022
• FIGURE 22 CELL-BASED ASSAYS MARKET: SUPPLY CHAIN ANALYSIS
• FIGURE 23 CELL-BASED ASSAYS MARKET: VALUE CHAIN ANALYSIS
• FIGURE 24 PRICING ANALYSIS FOR CELL-BASED ASSAY PRODUCTS
• FIGURE 25 CELL-BASED ASSAYS MARKET ECOSYSTEM
• FIGURE 26 REVENUE SHIFTS IN CELL-BASED ASSAYS MARKET
• FIGURE 27 NUMBER OF PATENTS GRANTED, 2014-2023
• FIGURE 28 TOP TEN PATENT APPLICANTS, 2014-2024
• FIGURE 29 CELL-BASED ASSAYS MARKET: PORTERS FIVE ANALYSIS
• FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL-BASED ASSAY PRODUCTS
• FIGURE 31 KEY BUYING CRITERIA FOR END USERS
• FIGURE 32 CELL-BASED ASSAYS MARKET: INVESTMENTS & FUNDING SCENARIO
• FIGURE 33 INSTRUMENTS MARKET (FLOW CYTOMETERS) FOR CELL-BASED ASSAYS, 2022-2029 (THOUSAND UNITS)
• FIGURE 34 WORLDWIDE TOTAL PHARMACEUTICAL R&D SPEND, 2021-2028
• FIGURE 35 NORTH AMERICA: CELL-BASED ASSAYS MARKET SNAPSHOT
• FIGURE 36 ASIA PACIFIC: CELL-BASED ASSAYS MARKET SNAPSHOT
• FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN CELL-BASED ASSAYS MARKET (2021-2023)
• FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL-BASED ASSAYS MARKET (2023)
• FIGURE 39 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
• FIGURE 40 CELL-BASED ASSAYS MARKET: COMPANY FOOTPRINT
• FIGURE 41 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2023
• FIGURE 42 EV/EBITDA OF KEY VENDORS
• FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 44 CELL-BASED ASSAYS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
• FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 46 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
• FIGURE 47 MERCK KGAA: COMPANY SNAPSHOT (2023)
• FIGURE 48 BD: COMPANY SNAPSHOT (2023)
• FIGURE 49 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
• FIGURE 50 LONZA: COMPANY SNAPSHOT (2023)
• FIGURE 51 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
• FIGURE 52 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2023)
• FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
• FIGURE 54 REVVITY: COMPANY SNAPSHOT (2023)
• FIGURE 55 SARTORIUS AG: COMPANY SNAPSHOT (2023)
• FIGURE 56 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
• FIGURE 57 ENZO BIOCHEM INC.: COMPANY SNAPSHOT (2023)
• FIGURE 58 CARNA BIOSCIENCES, INC.: COMPANY SNAPSHOT (2023)
• FIGURE 59 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2023)
• FIGURE 60 BICO: COMPANY SNAPSHOT (2023)